An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient
COVID-19 can cause serious respiratory complications resulting in the need for invasive ventilatory support and concurrent aerosol therapy. Aerosol therapy is considered a high risk procedure for the transmission of patient derived infectious aerosol droplets. Critical-care workers are considered to...
Main Authors: | Marc Mac Giolla Eain, Mary Joyce, Ronan MacLoughlin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2021.1951893 |
Similar Items
-
How to optimize aerosol drug delivery during noninvasive ventilation: What to use, how to use it, and why?
by: Arzu Ari
Published: (2019-01-01) -
AEROSOL THERAPY DURING NON-INVASIVE VENTILATION
by: S. N. Аvdeev
Published: (2018-05-01) -
Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
by: Niamh Woods, et al.
Published: (2020-09-01) -
In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy
by: Gavin Bennett, et al.
Published: (2019-02-01) -
The Effect of Aerosol Devices and Administration Techniques on Drug Delivery in a Simulated Spontaneously Breathing Pediatric Model with a Tracheostomy
by: Alhamad, Bshayer R
Published: (2013)